Report cover image

In-Silico Drug Discovery Market by Molecule Type (Antibodies, Nucleic Acids, Peptides), Workflow (Bioinformatics, Clinical Trials, Discovery), Therapeutic Area, End User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 195 Pages
SKU # IRE18444788

Description

In-Silico Drug Discovery Market by Molecule Type (Antibodies, Nucleic Acids, Peptides), Workflow (Bioinformatics, Clinical Trials, Discovery), Therapeutic Area, End User - Global Forecast 2024-2030


The In-Silico Drug Discovery Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.86 billion in 2024, at a CAGR 8.71% to reach USD 4.83 billion by 2030.

Global In-Silico Drug Discovery Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In-Silico Drug Discovery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In-Silico Drug Discovery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In-Silico Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include Abzena Ltd., Aragen Life Sciences Pvt. Ltd., BioDuro LLC, BioNTech SE, Certara, Inc., Charles River Laboratories International, Inc., Chemical Computing Group ULC, ChemPartner PharmaTech Co Ltd, Creative Biostructure, Curia Global Inc., Evotec SE, GenScript Biotech Corporation, InSilico Medicine, Ligand Pharmaceuticals Incorporated, Schrödinger Inc., Selvita S.A., Simulations Plus, Inc., Sygnature Discovery, Viva Biotech Holding Group, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Silico Drug Discovery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Molecule Type
Antibodies

Nucleic Acids

Peptides

Proteins

Vectors

Workflow
Bioinformatics

Clinical Trials

Discovery

Preclinical Tests

Protein Structure Prediction

Reverse Docking

Target Identification

Therapeutic Area
Blood Disorders

Infectious Diseases

Mental Disorders

Metabolic Disorders

Musculoskeletal Disorders

Neurological Disorders

Oncological Disorders

Respiratory Disorders

Skin Disorders

End User
Academic & Research Institutes

Contract Research Organizations

Pharmaceutical Manufacturers

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In-Silico Drug Discovery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In-Silico Drug Discovery Market?
3. What are the technology trends and regulatory frameworks in the In-Silico Drug Discovery Market?
4. What is the market share of the leading vendors in the In-Silico Drug Discovery Market?
5. Which modes and strategic moves are suitable for entering the In-Silico Drug Discovery Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

195 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. In-Silico Drug Discovery Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diseases and increase in drug discovery
5.1.1.2. Improvement in computational models and simulations
5.1.1.3. Inclination towards personalized medicine approach
5.1.2. Restraints
5.1.2.1. Concerns associated with data integration
5.1.3. Opportunities
5.1.3.1. Integration of advanced technologies in in-silico drug discovery
5.1.3.2. Ongoing R&D to drive innovation in in-silico drug discovery
5.1.4. Challenges
5.1.4.1. Complex process and dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. In-Silico Drug Discovery Market, by Molecule Type
6.1. Introduction
6.2. Antibodies
6.3. Nucleic Acids
6.4. Peptides
6.5. Proteins
6.6. Vectors
7. In-Silico Drug Discovery Market, by Workflow
7.1. Introduction
7.2. Bioinformatics
7.3. Clinical Trials
7.4. Discovery
7.5. Preclinical Tests
7.6. Protein Structure Prediction
7.7. Reverse Docking
7.8. Target Identification
8. In-Silico Drug Discovery Market, by Therapeutic Area
8.1. Introduction
8.2. Blood Disorders
8.3. Infectious Diseases
8.4. Mental Disorders
8.5. Metabolic Disorders
8.6. Musculoskeletal Disorders
8.7. Neurological Disorders
8.8. Oncological Disorders
8.9. Respiratory Disorders
8.
10. Skin Disorders
9. In-Silico Drug Discovery Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Pharmaceutical Manufacturers
10. Americas In-Silico Drug Discovery Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific In-Silico Drug Discovery Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.
10. South Korea
11.
11. Taiwan
11.
12. Thailand
11.
13. Vietnam
12. Europe, Middle East & Africa In-Silico Drug Discovery Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.
10. Nigeria
12.
11. Norway
12.
12. Poland
12.
13. Qatar
12.
14. Russia
12.
15. Saudi Arabia
12.
16. South Africa
12.
17. Spain
12.
18. Sweden
12.
19. Switzerland
12.
20. Turkey
12.
21. United Arab Emirates
12.
22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abzena Ltd.
14.1.2. Aragen Life Sciences Pvt. Ltd.
14.1.3. BioDuro LLC
14.1.4. BioNTech SE
14.1.5. Certara, Inc.
14.1.6. Charles River Laboratories International, Inc.
14.1.7. Chemical Computing Group ULC
14.1.8. ChemPartner PharmaTech Co Ltd
14.1.9. Creative Biostructure
14.1.
10. Curia Global Inc.
14.1.
11. Evotec SE
14.1.
12. GenScript Biotech Corporation
14.1.
13. InSilico Medicine
14.1.
14. Ligand Pharmaceuticals Incorporated
14.1.
15. Schrödinger Inc.
14.1.
16. Selvita S.A.
14.1.
17. Simulations Plus, Inc.
14.1.
18. Sygnature Discovery
14.1.
19. Viva Biotech Holding Group
14.1.
20. WuXi AppTec
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. IN-SILICO DRUG DISCOVERY MARKET RESEARCH PROCESS
FIGURE 2. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. IN-SILICO DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IN-SILICO DRUG DISCOVERY MARKET DYNAMICS
FIGURE 7. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
FIGURE 8. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 10. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 12. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. IN-SILICO DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IN-SILICO DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN-SILICO DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IN-SILICO DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IN-SILICO DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us